Clinical Trial Update: Documentation of Efficacy of Intralymphatic Allergen Immunotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial has completed and documents the efficacy of intralymphatic allergen immunotherapy for grass pollen–related allergic rhinitis, allergic co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis
• Asthma

Drugs mentioned

• Intralymphatic allergen immunotherapy (intralymphatic allergen immunotherapy)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Allergic Rhinitis Due to Grass Pollen, Allergic Conjunctivitis of Both Eyes | Phase 3 | Status: COMPLETED